SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-001766
Filing Date
2020-02-07
Accepted
2020-02-07 16:05:34
Documents
7
Period of Report
2020-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 47716
2 ex1-1.htm EX-1.1 322370
3 ex5-1.htm EX-5.1 12358
4 ex99-1.htm EX-99.1 15600
5 ex99-2.htm EX-99.2 15565
6 ex99-1_001.jpg GRAPHIC 14510
7 ex99-2_001.jpg GRAPHIC 13044
  Complete submission text file 0001493152-20-001766.txt   453041
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 20587403
SIC: 2834 Pharmaceutical Preparations